C.D.C. advisers are meeting to discuss Novavax’s Covid vaccine.

The F.D.A. last week authorized the vaccine as a primary immunization for adults. The C.D.C.’s full approval is the shot’s last regulatory hurdle.

BY REBECCA ROBBINS AND CARL ZIMMER | NYTimes Health | Disclosure